Mackenzie Financial Corp Moderna, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 30,206 shares of MRNA stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,206

Previous 47,638 36.59%

Holding current value

$1.2 Million

Previous $5.66 Million 64.33%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $1.11 Million - $2.18 Million	-17,432 Reduced 36.59%	30,206 $2.02 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $405,346 - $667,273	-4,005 Reduced 7.76%	47,638 $5.66 Million
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $5.41 Million - $7.31 Million	-63,364 Reduced 55.1%	51,643 $5.5 Million
Q4 2023 Jan 30, 2024	BUY	$69.51 - $104.43 $3.26 Million - $4.9 Million	46,964 Added 69.02%	115,007 $11.4 Million
Q3 2023 Oct 25, 2023	BUY	$96.41 - $126.61 $205,835 - $270,312	2,135 Added 3.24%	68,043 $7.03 Million
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $111,153 - $150,577	938 Added 1.44%	65,908 $8.01 Million
Q1 2023 Apr 24, 2023	SELL	$135.66 - $197.02 $2.61 Million - $3.79 Million	-19,259 Reduced 22.87%	64,970 $9.98 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $832,684 - $1.48 Million	-7,034 Reduced 7.71%	84,229 $15.1 Million
Q3 2022 Oct 07, 2022	SELL	$118.07 - $194.18 $552,095 - $907,985	-4,676 Reduced 4.87%	91,263 $10.8 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $358,769 - $540,895	3,063 Added 3.3%	95,939 $13.7 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $3.2 Million - $5.95 Million	25,299 Added 37.44%	92,876 $16 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $67,520 - $110,184	-299 Reduced 0.44%	67,577 $17.2 Million
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $78,108 - $170,533	352 Added 0.52%	67,876 $26.1 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $537,957 - $973,052	4,141 Added 6.53%	67,524 $15.9 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.22 Million - $2.08 Million	11,198 Added 21.46%	63,383 $8.3 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $761,860 - $1.97 Million	-11,589 Reduced 18.17%	52,185 $5.45 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $653,873 - $1.14 Million	12,033 Added 23.26%	63,774 $4.51 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $1.54 Million - $4.14 Million	51,741 New	51,741 $3.32 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Moderna, Inc. Transaction History